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Introduction
Chronic obstructive pulmonary disease is a major
cause of morbidity, disability and mortality in old
age.1-3 The disease is characterized by shortness of
breath, impaired ventilatory function and easy
fatiguability. These are the most distressing and
disabling symptoms of COPD, limiting exercise
tolerance, interfering with basic activities of daily
living and often, in turn, impairing quality of 
life.4-6
Community surveys in the United Kingdom
have reported the prevalence of respiratory symp-
toms as a potential cause for significant disability
in old age at between 30% and 60%.7–8 Others
argue that respiratory symptoms are under-recog-
nized in elderly people,9 in whom respiratory con-
ditions are often asymptomatic in their
presentation. However, despite this, elderly com-
munity-dwellers cite chest problems as a cause of
severe disability second only to musculoskeletal
disorders.10  COPD is a primary cause of death in
all age-groups in the UK and four-fifths of all
deaths due to COPD occur in individuals aged 70
or older.2 It is ranked as the fourth leading cause
of death in the US.11
The impact of respiratory symptoms on elderly
people is complex and affects different aspects of
an individual’s life. Psychological status plays an
important role in maintaining independence in old
age.12 Undiagnosed and untreated anxiety and
depressive symptoms may relate to physical dis-
ability, impaired quality of life and increased
health care utilization.13–14 They may also interfere
with compliance with medical treatment and
accelerate mortality.13,15,16 Chronic obstructive
pulmonary disease in old age may have a devas-
tating effect. The disease progresses in a subtle
way and may gradually incapacitate the patient to
a level of dependence in daily activities. 
Prevalence of depression and anxiety in elderly
patients with COPD
The current review provided the opportunity to
conduct a meta-analysis of studies of anxiety 
and depression in elderly patients with COPD.
The aims of this review were to estimate the preva-
lence of depression and anxiety symptoms and to
investigate the consequences in patients with
chronic obstructive pulmonary disease. Electronic
searches were performed for English citations
using the databases, Medline (1966–1998), Psych-
lit (1984–1998) and Cinhal (1982–1998). The fol-
lowing key words were used: ‘COPD’, ‘depression’
and ‘anxiety’. The bibliographies of articles so
extracted were scrutinized to identify other poten-
tially relevant articles.
Studies were included in the analysis, provided
that they included patients with chronic obstruc-
tive pulmonary disease as the principal diagnosis
and reported the prevalence of depressive and anx-
iety symptoms in percentage terms. A number of
studies were excluded, as they only reported mean
scores of depressive or anxiety symptoms. A stan-
dard measure of effect size was calculated for each
trial and weighted pooled estimates were obtained
to estimate the prevalence of depressive symptoms
and anxiety in this patient group.
Eleven studies were identified with a percentage
score of depressive symptoms and nine studies
Mood disorders in elderly patients with chronic
obstructive pulmonary disease
Abebaw M Yohannes and Robert C Baldwin
Manchester Royal Infirmary, Manchester, UK
Martin J Connolly
University of Manchester, Manchester, UK
Address for correspondence: A Yohannes, Manchester
School of Physiotherapy, Manchester Royal Infirmary,
M13 9WL, UK.
with anxiety symptoms. For all studies with
depressive or anxiety symptoms, we performed
pooled effect-size analysis giving best estimates of
prevalence of depression or anxiety (95% confi-
dence limits). The total population studied com-
prised 900 subjects; the best estimate of prevalence
of depression was 40% (36–44 %), and for anxi-
ety symptoms (total population 539), 36%
(31–41%).
Thus in the meta-analysis, combined effect sizes
for depressive and anxiety symptoms were very
high in this patient group (Table 1) and compara-
ble to those in idiopathic Parkinson’s disease or
brain damage due to stroke.29,30 However, none of
the articles reviewed gave details of the effects of
treatment on these symptoms. Furthermore, the
methodological variation, different assessment
tools used and differences in sample populations
in the studies examined is acknowledged. Recently
van Ede et al.31 has addressed these issues in a
review which included the articles in this meta-
analysis. 
In the analysis, most of the studies used screen-
ing tools (rather than diagnostic instruments),
except two which employed a psychiatric inter-
view using DSM III-R criteria (of the American
Psychiatric Association) (Table 1). Screening ques-
tionnaires provide an estimate of the prevalence of
depressive symptoms and are used to identify
potential ‘cases’ of clinical depression. The preva-
lence of depressive symptoms in COPD, sufficient
to be of clinical importance, range between 7%
and 46%, and that of anxiety up to 49%
(Table 1). 
If the problem is so great, why is it often undi-
agnosed and untreated? Firstly, screening tools for
depression or anxiety symptoms are not routinely
used in clinical practice. Secondly, symptoms of
depression and anxiety in patients with COPD
might be masked by physical symptoms, such as
decrease in exercise tolerance, breathlessness,
fatigue and increased dependence in daily activi-
ties. Furthermore, in patients with COPD, poor
health, bouts of chest infection and frequent
episodes of hospital admission are so common as
to be an almost accepted scenario for many
patients. In this context, patients may not disclose
symptoms of depression or anxiety unless they are
specifically asked.32 Other contributory factors
might be that not all physicians are confident
enough to pursue psychiatric assessment and
patients may fear approaching their physicians
because of the stigma of mental illness. Lack of
public awareness fuels this stigma,33 and depres-
sion itself is associated with its own specific
stigma.34
The interaction of psychiatric symptoms 
and COPD
It has been suggested that untreated depression
may interfere with medical treatment and in turn
increase health and social service care utilization,
leading to higher mortality in the initial phase of
hospitalization.15 Identification of clinical depres-
sion or anxiety thus becomes important in itself.
Identification is also needed for optimal manage-
ment of the older patient with COPD. 
Because of the chronic nature of their illness,
elderly COPD patients are prone to chest infec-
tions, and these and other exacerbations are a
cause of frequent hospitalization. Although the
effect of this may be difficult to quantify, these are
clearly adverse events and impair patients’ confi-
dence in their ability to manage their illness,
which, in turn, may subsequently produce or exac-
erbate depressive symptoms.35 Previous studies
suggest that patients with COPD suffer from dis-
ease-related, high ‘emotional stress’, leading to
behavioural changes, such as increased irritability
and social withdrawal.36–38 Patients tend to
employ psychological mechanisms, such as denial
or rationalization, to cope and these too may lead
to maladaptive behaviour, such as the refusal to
go to hospital during an exacerbation. They may
also come to fear that any activity will trigger
worsening of their breathing difficulties to the
point where participation in social activities is
completely and irrationally avoided. Thus inde-
pendence decreases and is replaced by a growing
dependence on medical care. 
Discrepancy in the reported rates of depressive
symptoms
The lowest prevalence of depressive symptoms
was identified by Engstrom et al.25 at 7% and the
highest was in our own studies,19 at 46%. This
huge reported discrepancy may be partly
explained by the age group of subjects studied. In
the former, the age range was 40–75 (mean 64)
years, and statistically there was no difference in
the prevalence of depressive symptoms compared
to age–sex-matched controls. However, our own
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studies investigated older COPD patients aged
70–93 (mean 78) years, and also employed two
age–sex-matched control groups in whom the
prevalence of depressive symptoms was 26% (for
disabled controls) and 11% (for normal controls).
However, other studies17,18 have reported a 42%
prevalence of depression in younger COPD
patients, suggesting that age per se is not the main
factor accounting for these differences. Other
areas thus need exploration, for example, the
socio-economic status of the subjects and the
validity of the assessment tools used. 
Two studies reported that in old age, women
tend to report less life satisfaction and higher level
of depressive symptoms than men.26,39 This may
be explained by the greater role loss in women
compared to men, when disabled by COPD. Tra-
ditionally, women are expected to be homemak-
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Table 1. Characteristics of studies
Studies Screening tool Prevalence in % Source of  subjects Mean age N M F
Anxiety Depression
Yohannes BASDEC n 46 Outpatient 78 96 56 40
et al. 1998
Yellow DSM III criteria 34 16 Inpatient 65 50 32 18
et al. 1987
McSweeny MMPI n 42 Outpatient 65 203 160 43
et al. 1982
Light BDI STAI 2 42 Outpatient 62 45 n n
et al. 1985
Isoaho ZDS 26 Outpatient 71 83 61 21
et al. 1995
Borak BDI MAS 38 79 Outpatient 57 58 34 14
et al. 1991
Engstorm HAD 13 7 Outpatient Inpatient 64 68 43 25
et al. 1996
White HAD 40 32 Outpatient 66 44 28 16
et al. 1997
Eiser HAD 55 n Outpatient 72 18 8 10
et al. 1997
Bosley HAD 28 20 Outpatient 65 93 48 45
et al. l996 
Jones HAD 47 29 Outpatient 63 141 92 41
et al. 1989
Ries CES-D n 24 Outpatient 63 119 87 32
et al. 1995
Karajgi DSM-III- R 16 n Outpatient 65 50 31 19
et al. 1990
Keys
HAD = Hospital Anxiety and Depression Scale
BASDEC = Brief Assessment Schedule Depression Cards
BDI = Beck Depression Inventory
MAS = Taylor Manifest Anxiety Scale
ZDS = Zung Depression Scale
MMPI = Minnesota Multiphasic Personality Inventory
STAI = State Trait Anxiety Inventory
DSM III = Diagnostic and Statistical Manual of Mental Disorders 
CES-D = Centres for Epidemiologic Studies Depression Scale
n = not performed or documented
ers, care for the family and be responsible for a
larger proportion of domestic activities, all of
which are severely undermined by COPD. The
possible differential effects of gender need to be
borne in mind. 
Comparisons of depressive symptoms associated
with other chronic diseases
Depression is a common problem for older peo-
ple. The prevalence of the illness is approximately
10% for those who are aged above 65.40,41 How-
ever, for patients who are hospitalized with acute
medical conditions, the prevalence ranges from
10% to 45%.32 In the current meta-analysis, the
prevalence of depressive symptoms (40%) is sim-
ilar to that reported in other chronic diseases, such
as idiopathic Parkinson’s disease (about 40%),29
and higher than that reported in coronary heart
disease (25%).42 
In studies comparing emotional distress in
COPD patients with that of patients with other
chronic illnesses, patients with COPD more com-
monly tend to report feelings of uselessness, loss
of social role and decreased libido.36,43 Schlenk et
al.44 investigated six chronic diseases (urinary
incontinence, prostate cancer, acquired immune
deficiency syndrome, fibromyalgia, hyper-lipi-
daemia and COPD), and assessed their impact on
quality of life, using the Medical Outcomes Study
Short Form-36. In this study, COPD subjects had
the lowest quality of life in the domains of role-
physical, role-emotional and mental health.
Role loss and what to do with their time is a
big problem for many older COPD subjects. Dys-
pnoea on exertion is the main problem causing
subjects to divert their attention towards seden-
tary activities. In severe hypoxaemic subjects
sedentary and more ‘intellectual’ pursuits may also
become a problem because of impaired concen-
tration and mental processing related to hypox-
aemia. 
Factors that might be associated with depressive
symptoms in COPD
The causes of depressive symptoms in COPD
patients are complex. In moderate to severe
hypoxemic COPD patients, depressive symptoms
seem to be associated with age and low socio-eco-
nomic status18 and closely associated with the
degree of physical disability and impairment of
quality of life.19 Hypoxaemia itself is also associ-
ated with impaired quality of life.45 The onset of
depression has been identified as a risk factor for
developing cognitive decline in hypoxaemic COPD
patients.46
The use of life-prolonging long-term oxygen
therapy (LTOT) in the chronic hypoxaemia of
COPD may have major implications for patients’
everyday life. Some patients feel tied to the oxy-
gen apparatus and become restricted not only out-
side, but even within the home. Although studies
have investigated the efficacy of oxygen therapy in
improving functional performance and quality of
life, they have not generally addressed psychoso-
cial implications. The recent findings by Monso et
al.47 confirm that long-term oxygen users suffer
severe quality of life impairment and are prone to
emotional lability and social isolation. Interest-
ingly, Strom48 recently identified that, in male and
female patients who use oral corticosteroids with
long-term oxygen therapy, women are more sus-
ceptible than men to frequent hospitalization and
early death.
Are intervention strategies effective in treating
anxiety and depressive symptoms?
Pulmonary rehabilitation
The British Thoracic Society (BTS) and American
Thoracic Society (ATS) guidelines11,49 emphasize
the need for pulmonary rehabilitation of COPD
patients to enhance general wellbeing, improve
quality of life and improve independence. Several
randomized controlled trials in inpatient and out-
patient pulmonary rehabilitation programmes
have reported significant improvements in quality
of life, reduced symptoms of dyspnoea and
increased exercise tolerance.50–52 However, very
few studies have reported even a meagre improve-
ment in symptoms of anxiety and depression.22,55
Possible explanations for this discrepancy include
the difficulties of using screening questionnaires
(not validated in this patient group) and variabil-
ity in cut-off points to diagnose a case of depres-
sion or anxiety. 
Even if they identify depressive symptoms,
screening instruments may not be sufficiently sen-
sitive to detect subtle changes during rehabilita-
tion programmes, therefore designing and
validating disease-specific scales is worthwhile. 
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Psychotherapy and cognitive behavioural therapy
Eiser et al.21 conducted a six-week psychotherapy
programme led by a psychiatrist and revealed sig-
nificant improvement in exercise tolerance but no
change in anxiety or depressive symptoms. The
programme was aimed at disentangling the root
cause(s) of anxiety symptoms from the coping
strategies used to overcome problems. Others have
claimed success for psychotherapy and relaxation
therapy in improving dyspnoea and anxiety symp-
toms in COPD.53,54 It is difficult to determine
whether positive effects are specifically due to the
type and content of therapy or because of simpler
explanations, such as the use of relaxation, or
because patients received attention. However,
Emery et al.55 in three groups of COPD patients,
compared the efficacy of (1) exercise training com-
bined with psychotherapy and education (2) edu-
cation and psychotherapy and (3) education alone.
Their findings suggest that those in the first group
showed significant improvement in endurance,
reduced anxiety and increased cognitive perfor-
mance, with no improvement observed in the
other two groups. 
Psycho-education
A recent meta-analysis by Devine and Pearcy56
examined the benefits of psycho-education (exer-
cise training accompanied by education and psy-
chosocial support) in COPD. In seven studies they
observed significant improvement in endurance,
functional status and psychological wellbeing. In
other studies, intensive education for COPD
patients has led to significant reduction in health
care utilization and also increased knowledge
about self-management of the disease,57 for exam-
ple, early patient self-referral to GPs or hospital
before the acute exacerbation reaches a severe
condition. Others have suggested controlling fac-
tors that may trigger acute exacerbation may
reduce hospital admission and improve quality of
life.58 A very recent study by Gallefoss et al.59
compared patient education of asthmatic and
COPD patients. Their findings suggest that edu-
cation led to significant improvement in quality of
life and forced expiratory volume in asthmatic
patients, but not in COPD patients. Caution is
needed in interpreting the result of this study, as
there was wide variation in the age group of the
subjects (that of COPD subjects was 57 years, c.f.
41 years for asthmatics). Furthermore, the COPD
patients had a longer duration of illness (median
15 years, cf. seven years for asthmatics) and the
improvement in FEV1 in the asthmatic group sug-
gests poor control of disease prior to inclusion in
the study. 
Antidepressant use in COPD patients
The literature is sparse regarding the use of anti-
depressants in COPD. Two studies have attempted
to examine the efficacy of antidepressants in
COPD patients and both were inconclusive. Pre-
viously, in a double-blind crossover study, Gordon
et al.60 compared the efficacy of desipramine with
that of placebo in younger age-range COPD
patients (N=13, mean age 63 years), with the find-
ing that desipramine was poorly tolerated in this
patient group. In this study, seven of the subjects
withdrew due to acute exacerbations, side-effects
(dry mouth, sleep disturbance, urinary retention,
fatigue and tremor) and other concomitant
medical problems. Koenig et al.61 in a study of
medically ill patients had difficulties recruiting
subjects because of medical contraindications,
such as delirium, bladder outlet obstruction, sever-
ity of the overall illness, cancer and patient
refusals.
Recently, in this department, the feasibility of
using the SSRI fluoxetine in elderly COPD patients
has been investigated. Fluoxetine is recognized to
be effective and well-tolerated in frail ill elderly
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Table 2. Side-effects reported by COPD patients taking fluoxetine
• Nausea
• General tiredness
• Loss of weight
• Tremor
• Dizziness
• Anxiety
• Marked irritability towards family problems
people.2 We recruited 14 elderly COPD patients in
an open, single-blinded study of 20mg/day fluox-
etine therapy for six months.63 Of these, seven
subjects did not complete the study. Five of the
subjects withdrew because of side-effects (Table
2), one due to family problems and one patient
died of a cause unrelated to antidepressants. 
However, perhaps the most important finding
of this pilot study was the reluctance of patients,
identified as depressed by a well-validated psychi-
atric tool, the Geriatric Mental Status Schedule,64
to accept treatment with fluoxetine. Seventy per
cent of depressed patients (N=57) refused antide-
pressant treatment, the common reasons for
refusal being fear of side-effects, embarrassment,
denial of depression, worries about addiction and
a frustration with taking ‘too many drugs’. Reluc-
tance to accept either the diagnosis or treatment
for depression has been previously reported in
elderly patients with depression associated with
other chronic medical conditions.61
Psychiatric co-morbidity (depression plus
anxiety) in COPD 
Depressive and anxiety symptoms are common in
COPD patients (Table 1). These studies, however,
did not investigate the overlap between anxiety
and depressive symptoms. In a pilot investigation
in this department,65 the overlap of anxiety symp-
toms with depression in elderly patients with
COPD was further explored. In the same group
of depressed elderly COPD patients (N=57)
described above, the prevalence of anxiety symp-
toms was found to be 34%, whereas in non-
depressed patients (N=80), it was only 5%. This
suggests a striking association between symptoms
of depression and anxiety. Caution is needed in the
interpretation of these findings, not least because
the subjects studied were residents of the inner
city, where socio-economic problems are often
prevalent. Furthermore, this cross-sectional study
cannot say to what extent the anxiety and depres-
sive symptoms arose simultaneously or were
sequential, with one disorder secondary to the
other.66 A longitudinal study is therefore worth
consideration. 
Many studies have reported18,36,37,67 that anxi-
ety and depressive symptoms are better predictors
of quality of life than lung function parameters.
Depression is associated with reduced social inter-
action and role functioning.38,43 Other studies
have identified physical disability associated with
depressive symptoms.18,19,20 Further, findings by
Wells et al.68 confirm that depressive symptoms
are related to subjects’ functional wellbeing. It is
a common clinical scenario that many COPD
patients present with sleep disturbance, reduced
energy level, difficulties in performing daily activ-
ities and reduced social interaction. Attributing
such symptoms purely to COPD may mean that
the diagnosis of depression is overlooked.19 A
standard clinical interview will often fail to iden-
tify depression in chronic medical illness: the use
of a psychiatric screening questionnaire in these
circumstances is strongly recommended.32
Depression in COPD and carers
Keele-Card et al.69 examined loneliness and
depression in a sample of 30 COPD patients and
their spouses. Their findings suggest that there was
no difference in mean scores of loneliness and
depression between the two groups. Similar find-
ings were reported by Meara et al.,70 who studied
the prevalence of depression in elderly Parkinson’s
patients (64%), their spouses and carers (34%). In
a community survey, Livingston et al.71 compared
the prevalence of depressive symptoms in carers
with that in co-residents of elderly people with
dementia, depression or physical disability. Their
findings revealed a higher prevalence of depressive
symptoms in carers than in co-residents (24% c.f.
11%, p < 0.05) and that symptoms were most
common in women caring for dementia patients.
Similar findings have also been observed in carers
of stroke patients.72 Depression in a patient with
COPD may trigger depression in a carer but the
reverse may also be true. For example, in prog-
nostic studies of depression in psychiatric practice,
depression in a carer is strongly correlated with
poor outcome,73 and the belief by a carer that a
depressed person is ‘putting it on’ also has a major
negative effect on the outcome of depression.74
These findings have not been reproduced in
patients with physical disability such as COPD,
but there seems little reason to deny the existence
of a ‘vicious circle’ in this patient group as well. 
Interestingly, the present research67 has sug-
gested that elderly subjects with COPD who live
alone seem better satisfied with their lives than
those who live with their spouses or relatives. This
may however have been a survival or migration
effect, those with more severe illness needing con-
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tinued help from ‘live-in’ carers. Although psy-
chosocial support plays an important role in the
ability of COPD patients to maintain independent
living, this may depend on the quality rather than
the quantity of support available. Moreover,
COPD patients may have a wider range of needs,
some of which may be complex, as the illness
affects various aspects of their lives in its progres-
sion. Psychosocial factors, such as a poor rela-
tionship with one’s spouse, have been implicated
in the prognosis of depression in old age.75 Reha-
bilitation programmes should address these issues. 
The wellbeing of carers is vitally important and
can influence the carer’s ability to provide care.
For health care professionals planning long-term
strategies for their patients, the welfare of the car-
ers should be considered in terms of respite care
or support in the community, and carer (as well
as patient) education. 
Health-care utilization in depressed patients 
with COPD
Poor general health, exacerbation and frequent
hospitalization is the fate of many COPD patients.
Retrospective uncontrolled studies suggest that
health care utilization in depressed patients is far
higher than that in non-depressed patients.65
These findings merely suggest that depression is
associated with longer treatment spells in the hos-
pital after recovering from acute exacerbations,
but do not tell us what other factors might be
associated with delayed discharge. Regueiro et
al.76 carried out an extensive study of 866 COPD
patients admitted with acute exacerbations.
Patients were divided into two groups, to be cared
for either by a pulmonologist or a generalist. Their
findings suggest no difference between the health-
care costs or survival of the two groups. Prospec-
tive controlled studies are required to confirm or
refute the effect of emotional status on health-care
use in COPD, and to address the value of the mul-
tidisciplinary team in supporting and resettling the
patient in the community.
Conclusion
Clinical anxiety and depressive symptoms are
common in patients with COPD. They are often
undiagnosed and untreated in this patient group.
Those with depressive symptoms are usually more
physically disabled and have greater impairment
of their quality of life. This argues for improved
detection of depression and for appropriate inter-
vention for anxiety and depressive symptoms in
patients with COPD. Such strategies should be
multi modal, i.e. involving the physical, psycho-
logical and social domains, and should closely
involve carers. There has been little evaluation of
the treatment of depression associated with
COPD.
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